Inhibitors of antigen presentation by MHC class II molecules

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8598312
APP PUB NO 20120252734A1
SERIAL NO

13523960

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compounds, pharmaceutical compositions containing such compounds and methods for their use. In particular, the compounds of the invention are useful for the treatment or prevention of diseases associated with T cell proliferation such as autoimmune diseases and disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PROVID PHARMACEUTICALS INCNORTH BRUNSWICK NJ 08902

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cook, Charles Michael Mendham, US 14 240
Olson, Gary Lee Mountainside, US 9 65
Self, Christopher Raymond West Caldwell, US 3 10

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 3, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00